NCT04439240 2021-06-29Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)National Cancer Institute (NCI)Phase 2 Completed52 enrolled 10 charts